Macquarie rates MLX as Outperform (1) - Production at both Nifty and Renison was slightly below Macquarie's estimates. Nevertheless, the broker is encouraged by the fact the company has opened up mining stopes outside the central zone at Nifty, which has resulted in an improvement in the grade.
Macquarie maintains an Outperform rating and $0.80 target.
- Forums
- ASX - By Stock
- MLX
- Ann: Increased Production at Nifty and Renison
MLX
metals x limited
Add to My Watchlist
4.59%
!
57.0¢

Ann: Increased Production at Nifty and Renison, page-9
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
57.0¢ |
Change
0.025(4.59%) |
Mkt cap ! $505.2M |
Open | High | Low | Value | Volume |
55.0¢ | 58.0¢ | 55.0¢ | $2.022M | 3.573M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 19522 | 56.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
57.0¢ | 50000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 19522 | 0.565 |
1 | 50000 | 0.560 |
1 | 50000 | 0.555 |
3 | 21799 | 0.550 |
2 | 54100 | 0.545 |
Price($) | Vol. | No. |
---|---|---|
0.575 | 50000 | 1 |
0.580 | 240517 | 4 |
0.585 | 59559 | 3 |
0.590 | 35000 | 1 |
0.595 | 100000 | 4 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
MLX (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online